Transfusion practices and infectious risks

References

• Murphy HM. The transmission of infectious hepatitis by blood transfusion. Gastroenterology. 1945;5:449–456.
   PubMed Web of Science ®Google Scholar
• Steiner RE. Jaundice after transfusion of whole blood or human plasma. Br Med J. 1944;1:110–111.
   PubMedGoogle Scholar
• Anderson I. AIDS panic disrupts American blood banks. New Sci. 1983;98:927.
   PubMed Web of Science ®Google Scholar
• Brailsford SR, Kelly D, Kohli H, et al. Who should donate blood? Policy decisions on donor deferral criteria should protect recipients and be fair to donors. Transfus Med. 2015;25:234–238.
   PubMed Web of Science ®Google Scholar
• Hughes S, Sheon N, Siedle-Khan B, et al. Saving lives, maintaining safety, and science-based policy: qualitative interview findings from the Blood Donation Rules Opinion Study (Blood DROPS). Transfusion. 2015;55:2835–2841.
   PubMed Web of Science ®Google Scholar
• Lieshout-Krikke RW, Zaaijer HL, van de Laar TJ. Predonation screening of candidate donors and prevention of window period donations. Transfusion. 2015;55:373–378.
   PubMed Web of Science ®Google Scholar
• Spreafico M, Berzuini A, Foglieni B, et al. Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy. J Hepatol. 2015;63:1068–1076.
   PubMed Web of Science ®Google Scholar
• Lindholm PF, Annen K, Ramsey G. Approaches to minimize infection risk in blood banking and transfusion practice. Infect Disord Drug Targets. 2011;11:45–56.
   PubMedGoogle Scholar
• Ballard T, Rohrbeck P, Kania M, et al. Transfusion-transmissible infections among U.S. military recipients of emergently transfused blood products, June 2006-December 2012. MSMR. 2014;21:2–6.
   PubMedGoogle Scholar
• Ziemann M, Hennig H. Prevention of transfusion-transmitted cytomegalovirus infections: which is the optimal strategy? Transfus Med Hemother. 2014;41:40–44.
   PubMed Web of Science ®Google Scholar
• Sobata R, Matsumoto C, Uchida S, et al. Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1. Vox Sang. 2015;109:122–128.
   PubMed Web of Science ®Google Scholar
• Douet JY, Bujdoso R, Andreoletti O. Leukoreduction and blood-borne vCJD transmission risk. Curr Opin Hematol. 2015;22:36–40.
   PubMed Web of Science ®Google Scholar
• Use of solvent/detergent-treated human plasma (octaplas): pilot project [Internet]. CADTH Optimal Use Reports 2011.
   Google Scholar
• Liumbruno GM, Franchini M. Solvent/detergent plasma: pharmaceutical characteristics and clinical experience. J Thromb Thrombolysis. 2015;39:118–128.
   PubMed Web of Science ®Google Scholar
• Schlenke P, Pathogen inactivation technologies for cellular blood components: an update. Transfus Med Hemother. 2014;41:309–325.
   PubMed Web of Science ®Google Scholar
• Funk MB, Heiden M, Volkers P, et al. Evaluation of risk minimisation measures for blood components - based on reporting rates of transfusion-transmitted reactions (1997-2013). Transfus Med Hemother. 2015;42:240–246.
   PubMed Web of Science ®Google Scholar
• Jackson BR, Busch MP, Stramer SL, et al., The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion. 2003;43:721–729.
   PubMed Web of Science ®Google Scholar
• Dodd RY, Foster GA, Stramer SL. Keeping blood transfusion safe from West Nile virus: American Red Cross experience, 2003 to 2012. Transfus Med Rev. 2015;29:153–161.
   PubMed Web of Science ®Google Scholar
• CDC. Detection of West Nile virus in blood donations–United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:769–772.
   PubMedGoogle Scholar
• Stramer SL, Hollinger FB, Katz LM, et al. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion. 2009;49(Suppl 2):1S–29S.
   PubMed Web of Science ®Google Scholar
• Stramer SL. Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. ISBT Sci Ser. 2014;9:30–36.
   PubMedGoogle Scholar
• Kleinman S, Stassinopoulos A. Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation. Transfusion. 2015;55:2983–3000.
   PubMed Web of Science ®Google Scholar
• Atreya C, Nakhasi H, Mied P, et al. FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety. Transfusion. 2011;51:1855–1871.
   PubMedGoogle Scholar
• Lafeuillade B, Eb F, Ounnoughene N, et al. Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008. Transfusion. 2015;55:636–646.
   PubMed Web of Science ®Google Scholar
• Klausen SS, Hervig T, Seghatchian J, et al. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients. Transfus Apher Sci. 2014;51:97–102.
   PubMed Web of Science ®Google Scholar
• Salunkhe V, van der Meer PF, de Korte D, et al. Development of blood transfusion product pathogen reduction treatments: a review of methods, current applications and demands. Transfus Apher Sci. 2015;52:19–34.
   PubMed Web of Science ®Google Scholar
• Butler C, Doree C, Estcourt LJ, et al. Pathogen-reduced platelets for the prevention of bleeding. Cochrane Database Syst Rev. 2013;3:CD009072.
   PubMed Web of Science ®Google Scholar
• Isbister JP, Shander A, Spahn DR, et al. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev. 2011;25:89–101.
   PubMed Web of Science ®Google Scholar
• Perros AJ, Christensen AM, Flower RL, et al. Soluble mediators in platelet concentrates modulate dendritic cell inflammatory responses in an experimental model of transfusion. J Interferon Cytokine Res. 2015;35:821–830.
   PubMed Web of Science ®Google Scholar
• Zimring JC. Established and theoretical factors to consider in assessing the red cell storage lesion. Blood. 2015;125:2185–2190.
   PubMed Web of Science ®Google Scholar
• Orlov D, Karkouti K. The pathophysiology and consequences of red blood cell storage. Anaesthesia. 2015;70(Suppl 1):29–12.
   PubMed Web of Science ®Google Scholar
• Qu L, Triulzi DJ. Clinical effects of red blood cell storage. Cancer Control. 2015;22:26–37.
   PubMed Web of Science ®Google Scholar
• Lacroix J, Hebert PC, Fergusson DA, et al. Age of transfused blood in critically ill adults. N Engl J Med. 2015;372:1410–1418.
   PubMed Web of Science ®Google Scholar
• Steiner ME, Ness PM, Assmann SF, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med. 2015;372:1419–1429.
   PubMed Web of Science ®Google Scholar
• Brunskill SJ, Wilkinson KL, Doree C, et al. Transfusion of fresher versus older red blood cells for all conditions. Cochrane Database Syst Rev. 2015;5:CD010801.
   PubMed Web of Science ®Google Scholar
• Mincheff MS, Meryman HT. Blood transfusion, blood storage and immunomodulation. Immunol Invest. 1995;24:303–309.
   PubMed Web of Science ®Google Scholar
• Kenz HE, van der LP. Transfusion-related acute lung injury. Eur J Anaesthesiol. 2014;31:345–350.
   PubMed Web of Science ®Google Scholar
• Brown CJ, Navarrete CV. Clinical relevance of the HLA system in blood transfusion. Vox Sang. 2011;101:93–105.
   PubMed Web of Science ®Google Scholar
• Hirayama F. Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. Br J Haematol. 2013;160:434–444.
   PubMed Web of Science ®Google Scholar
• Fast LD, Developments in the prevention of transfusion-associated graft-versus-host disease. Br J Haematol. 2012;158:563–568.
   PubMed Web of Science ®Google Scholar
• Shander A, Javidroozi M, Ozawa S, et al. What is really dangerous: anaemia or transfusion? Br J Anaesth. 2011;107(Suppl 1):i41–i59.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Wetterslev J, Sharma A, et al. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med. 2013;173:132–139.
   PubMed Web of Science ®Google Scholar
• Patel NN, Avlonitis VS, Jones HE, et al. Indications for red blood cell transfusion in cardiac surgery: a systematic review and meta-analysis. Lancet Haematol. 2015;2:e543–e553.
   PubMed Web of Science ®Google Scholar
• Carless PA, Henry DA, Carson JL, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2010;CD002042. doi:10.1002/14651858.CD002042.pub2
   Google Scholar
• Carson JL, Carless PA, Hebert PC, Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
   PubMedGoogle Scholar
• Holst LB, Petersen MW, Haase N, et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ. 2015;350:h1354.
   PubMed Web of Science ®Google Scholar
• Curley GF, Shehata N, Mazer CD, et al. Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: a systematic review and meta-analysis. Crit Care Med. 2014;42:2611–2624.
   PubMed Web of Science ®Google Scholar
• Murphy GJ, Pike K, Rogers CA, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med. 2015;372:997–1008.
   PubMed Web of Science ®Google Scholar
• Salisbury AC, Reid KJ, Marso SP, et al. Blood transfusion during acute myocardial infarction: association with mortality and variability across hospitals. J Am Coll Cardiol. 2014;64:811–819.
   PubMed Web of Science ®Google Scholar
• Ripolles MJ, Casans FR, Espinosa A, et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion in critically ill patients and in patients with acute coronary syndrome: a systematic review, meta-analysis and trial sequential analysis. Minerva Anestesiol. 2015. [Epub ahead of print]
   Google Scholar
• Fominskiy E, Putzu A, Monaco F, et al. Liberal transfusion strategy improves survival in perioperative but not in critically ill patients. A meta-analysis of randomised trials. Br J Anaesth. 2015;115:511–519.
   PubMed Web of Science ®Google Scholar
• Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA. 2010;304:1559–1567.
   PubMed Web of Science ®Google Scholar
• Imberger G, Gluud C, Boylan J, et al. Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection. Anesth Analg. 2015;121:1611–1622.
   PubMed Web of Science ®Google Scholar
• Dossetor JB, MacKinnon KJ, Gault MH, et al. Cadaver kidney transplants. Transplantation. 1967;5:844-53.
   PubMedGoogle Scholar
• Michielsen P, van YC. Experiences with kidney transplantation. Folia Med Neerl. 1966;9:98–106.
   PubMedGoogle Scholar
• Refaai MA, Blumberg N. Transfusion immunomodulation from a clinical perspective: an update. Expert Rev Hematol. 2013;6:653–663.
   PubMed Web of Science ®Google Scholar
• Hart S, Cserti-Gazdewich CM, McCluskey SA. Red cell transfusion and the immune system. Anaesthesia. 2015;70(Suppl 1):38–6.
   PubMed Web of Science ®Google Scholar
• Fragkou PC, Torrance HD, Pearse RM, et al. Perioperative blood transfusion is associated with a gene transcription profile characteristic of immunosuppression: a prospective cohort study. Crit Care. 2014;18:541.
   PubMed Web of Science ®Google Scholar
• Torrance HD, Brohi K, Pearse RM, et al. Association between gene expression biomarkers of immunosuppression and blood transfusion in severely injured polytrauma patients. Ann Surg. 2015;261:751–759.
   PubMed Web of Science ®Google Scholar
• Torrance HD, Vivian ME, Brohi K, et al. Changes in gene expression following trauma are related to the age of transfused packed red blood cells. J Trauma Acute Care Surg. 2015;78:535–542.
   PubMed Web of Science ®Google Scholar
• Shander A, Sazama K. Clinical consequences of iron overload from chronic red blood cell transfusions, its diagnosis, and its management by chelation therapy. Transfusion. 2010;50:1144–1155.
   PubMed Web of Science ®Google Scholar
• Porter JB, Garbowski M. The pathophysiology of transfusional iron overload. Hematol Oncol Clin North Am. 2014;28:683–701, vi.
   PubMed Web of Science ®Google Scholar
• Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822.
   PubMed Web of Science ®Google Scholar
• Munoz M, Gomez-Ramirez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion. 2014;54:289–299.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li H, Li B, et al. Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials. J Surg Res. 2011;171:e201–e207.
   PubMed Web of Science ®Google Scholar
• Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36:2667–2674.
   PubMed Web of Science ®Google Scholar
• Kato S, Chikuda H, Ohya J, et al. Risk of infectious complications associated with blood transfusion in elective spinal surgery-a propensity score matched analysis. Spine J. 2016;16:55–60.
   PubMed Web of Science ®Google Scholar
• Janssen SJ, Braun Y, Wood KB, et al. Allogeneic blood transfusions and postoperative infections after lumbar spine surgery. Spine J. 2015;15:901–909.
   PubMed Web of Science ®Google Scholar
• Friedman R, Homering M, Holberg G, et al. Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am. 2014;96:272–278.
   PubMed Web of Science ®Google Scholar
• Horvath KA, Acker MA, Chang H, et al. Blood transfusion and infection after cardiac surgery. Ann Thorac Surg. 2013;95:2194–2201.
   PubMed Web of Science ®Google Scholar
• Rogers MA, Micic D, Blumberg N, et al. Storage duration of red blood cell transfusion and Clostridium difficile infection: a within person comparison. PLoS One. 2014;9:e89332.
   PubMed Web of Science ®Google Scholar
• Vranken NP, Weerwind PW, Barenbrug PJ, et al., The role of patient’s profile and allogeneic blood transfusion in development of post-cardiac surgery infections: a retrospective study. Interact Cardiovasc Thorac Surg. 2014;19:232–238.
   PubMed Web of Science ®Google Scholar
• Rohde JM, Dimcheff DE, Blumberg N, et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA. 2014;311:1317–1326.
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med. 2014;127:124–131.
   PubMed Web of Science ®Google Scholar
• Brunskill SJ, Millette SL, Shokoohi A, et al. Red blood cell transfusion for people undergoing hip fracture surgery. Cochrane Database Syst Rev. 2015;4:CD009699.
   PubMedGoogle Scholar
• Teng Z, Zhu Y, Liu Y, et al. Restrictive blood transfusion strategies and associated infection in orthopedic patients: a meta-analysis of 8 randomized controlled trials. Sci Rep. 2015;5:13421.
   PubMed Web of Science ®Google Scholar
• WHO. Towards 100% voluntary blood donation: a global framework for action. WHO Guidelines Approved by the Guidelines Review Committee. Geneva: World Health Organization; 2010.
   Google Scholar
• Shander A, Gross I, Hill S, et al. A new perspective on best transfusion practices. Blood Transfus. 2013;11:193–202.
   PubMed Web of Science ®Google Scholar
• Goodnough LT, Shander A, Current status of pharmacologic therapies in patient blood management. Anesth Analg. 2013;116: 15–34.
   PubMed Web of Science ®Google Scholar
• Shander A, Javidroozi M, Perelman S, et al. From bloodless surgery to patient blood management. Mt Sinai J Med. 2012;79:56–65.
   PubMedGoogle Scholar
• Shander A, Hofmann A, Isbister J, et al. Patient blood management–the new frontier. Best Pract Res Clin Anaesthesiol. 2013;27:5–10.
   PubMedGoogle Scholar
• Lobel GP, Javidroozi M, Shander A. Risks of anemia in cardiac surgery patients. Semin Cardiothorac Vasc Anesth. 2015;19:288–292.
   PubMedGoogle Scholar
• Gross I, Shander A, Sweeney J. Patient blood management and outcome, too early or not? Best Pract Res Clin Anaesthesiol. 2013;27:161–172.
   PubMedGoogle Scholar